Does a balanced colloid decrease perioperative blood loss in paediatric cardiac surgery
Authors:
- 6 May 2021
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 38 (9) , 923-931
Abstract
BACKGROUND Unbalanced fluid solutions cause metabolic acidosis and could be associated with impaired coagulation and increased blood loss. OBJECTIVE To investigate whether the use of a balanced colloid compared with a saline colloid for peri-operative fluid therapy in children undergoing cardiac surgery is associated with decreased blood loss and exposure to blood products. DESIGN Double-blinded randomised controlled trial. SETTING Tertiary children's hospital from 2013 to 2016. PATIENTS Children older than 29 days and younger than 3 years admitted for cardiac surgery with cardiopulmonary bypass (CPB). Exclusion criteria were emergency cardiac surgery, moribund (American Society of Anesthesiologists 5), Jehovah's witnesses, coagulopathy, renal failure, liver injury, intracranial haemorrhage and electrolyte disturbances. From the 128 patients eligible, 88 were included in the study. INTERVENTION Random assignment of patients to either a saline colloid (6% hydroxyethyl starch 130/0.4 in 0.9% NaCl) or a balanced-electrolyte colloid (6% hydroxyethyl starch 130/0.4 in an isotonic solution) for CPB priming and intra- and postoperative fluid therapy during the first postoperative 48 h. MAIN OUTCOME MEASURE The primary outcome measure was calculated blood loss until the third postoperative day (POD3). RESULTS A total of 44 patients were included in each study arm. Calculated blood loss at POD3 was not significantly different between the groups (saline colloid 19.9 [IQR 13.8 to 26.1] ml kg−1 versus balanced colloid 15.9 [IQR 9.0 to 25.3 ml kg−1], P = 0.409). Secondary outcomes related to bleeding, exposure to blood products and coagulation were not different between groups. There was also no difference in length of mechanical ventilation, intensive care and hospital length of stay between groups. CONCLUSION The use of a balanced colloid for peri-operative fluid therapy compared with a saline one is not associated with decreased blood loss or exposure to blood products. TRIAL REGISTRATION EudraCT identifier: 2012-006034-17 and ClinicalTrial.gov identifier: NCT02584868.Keywords
This publication has 23 references indexed in Scilit:
- Vasoactive-Inotropic Score Is Associated With Outcome After Infant Cardiac SurgeryPediatric Critical Care Medicine, 2014
- A novel balanced isotonic sodium solution vs normal saline during major surgery in children up to 36 months: a multicenter RCTPediatric Anesthesia, 2014
- Comparison of low molecular weight hydroxyethyl starch and human albumin as priming solutions in children undergoing cardiac surgeryPerfusion, 2014
- Six Percent Hydroxyethyl Starch 130/0.4 (Voluven®) versus 5% Human Serum Albumin for Volume Replacement Therapy during Elective Open-heart Surgery in Pediatric PatientsAnesthesiology, 2013
- The Effect of HES (130/0.4) Usage as the Priming Solution on Renal Function in Children Undergoing Cardiac SurgeryRenal Failure, 2012
- Efficacy and Safety of Hydroxyethyl Starch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte) During Cardiac SurgeryJournal of Cardiothoracic and Vascular Anesthesia, 2011
- HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet functionCritical Care, 2009
- Perioperative volume replacement in children undergoing cardiac surgery: Albumin versus hydroxyethyl starch 130/0.4*Critical Care Medicine, 2009
- The Effect of Temperature and pH on the Activity of Factor VIIa: Implications for the Efficacy of High-Dose Factor VIIa in Hypothermic and Acidotic Patients2003
- Albumin versus crystalloid prime solution for cardiopulmonary bypass in young childrenCritical Care Medicine, 2002